Novo Nordisk Investor Presentation - First Nine Months of 2016

Investor presentation First nine months of 2016 All regions contribute to sales growth measured in local currencies for the first nine months of 2016 - Sales as reported – first nine months of 2016 Pacific +11% Region China +5% 8% 10% International Operations 12% changing diabetes 0% 19% Europe 0% Slide 5 Growth analysis - first nine months of 2016 Local currencies Growth Share of growth USA 6% 44% Europe 2% 6% International Operations 13% 27% USA 51% +5% Region China 11% 16% Pacific 6% 7% Total sales 6% 100% Sales of DKK 82,208 million (+4%) novo nordisk

View entire presentation